Perspectives and challenges for mother-to-child transmission of HIV, hepatitis B, and syphilis in Brazil

Datos Bibliográficos

ID22082591
AutoresAngélica Espinosa Miranda (0000-0002-5556-8379, Ministério da Saúde, autor de correspondencia), Patricia Carla Dos Santos (0000-0002-0606-4449, Ministério da Saúde), Ronaldo A Coelho (Ministério da Saúde), Ana Roberta Pati Pascom (0000-0002-2646-3383, Ministério da Saúde), Leonor Henriette De Lannoy (0000-0002-9520-8538, Ministério da Saúde), Ana Cristina Garcia Ferreira (Ministério da Saúde), Pâmela Cristina Gaspar (0000-0003-4642-0783, Universidade de Brasília), Ethel Leonor Noia Maciel (0000-0003-4826-3355, Ministério da Saúde), Ethel Leonor Maciel, Draurio Barreira (0000-0002-9626-7740, Ministério da Saúde), Gerson Fernando Mendes Pereira (0000-0001-8886-1662, Ministério da Saúde)
Año2023
Volumen11
Páginas1182386-1182386
Fecha de publicación2023-08-08
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaFrontiers in Public Health (JOURNAL)
Identificadores de la revistaISSN: 2296-2565 • E-ISSN: 2296-2565
EditorialFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2023.1182386
PMID37663837
OpenAlexW4385662111
IdiomaEN
Referencias citadas16

Background: Eliminating mother-to-child transmission (MTCT) of HIV, hepatitis B, and syphilis is a challenge in Brazil. Many policies have been implemented since 1986, but important gaps remain. This study aimed to describe the trends of MTCT in Brazil and evaluate the gaps and perspectives in this scenario. Methods: This is a descriptive study conducted with secondary data publicly available in the information systems of the Brazilian Ministry of Health regarding data on HIV, syphilis, and hepatitis B in pregnant women and children from 2011 to 2021. Results: HIV and hepatitis B have had constant rates over the years in pregnant women, with the detection rates around 2.5/1,000 live birth (LB) and 0.5/1.000LB, respectively. The same did not happen with syphilis, which has shown an increasing line in the last decade. In 2011, the detection rate of syphilis in pregnancy was 4.7/1,000LB, and in 2021 it reached 27.1/1,000LB. Regarding the trends in children, an important decrease was observed in HIV/AIDS (incidence rate from 0.18/1,000 in 2011 to 0.04/1,000 in 2021) and Hepatitis B (incidence rate from 0.9/1,000LB in 2011 to 0.5/1,000LB in 2021). For congenital syphilis, there is a continuous increase, being 3.3/1,000LB in 2011 and 9.9/1,000LB in 2021. Data from the HIV clinical monitoring showed that antiretroviral treatment coverage among pregnant women identified increased slightly between 2011 and 2021, in Brazil, from 92.3% to 94.3%. For syphilis, 82.5% of pregnant women were treated with benzathine penicillin, and 88.7% in 2011. The historical series of hepatitis B vaccination coverage in children has decreased over the years; it was 96% in 2013 and 76% in 2021. Conclusion: These data show many gaps and some perspectives in the MTCT program in Brazil. The country is close to reaching MTCT HIV elimination, but there are many challenges regarding HBV and syphilis. These data can be used to organize the strategies to improve the Brazilian response to MTCT elimination of HIV, hepatitis B, and syphilis

Christian ministry · Congenital syphilis · Environmental health · Hepatitis · Hepatitis B · Hepatitis C · Obstetrics · Pregnancy · Syphilis · Telecommunications · Demography · HIV/AIDS Research and Interventions · Maternal and Neonatal Healthcare · Medicine · Syphilis Diagnosis and Treatment · Immunology · Pediatrics